Costs, effects and cost-effectiveness of breast cancer control in Ghana

Tropical Medicine and International Health

Volumn 17, Issue 8, 2012, Pages 1031-1043

  Zelle, Sten G ^a   Nyarko, Kofi M ^b   Bosu, William K ^b   Aikins, Moses ^c   Niëns, Laurens M ^d   Lauer, Jeremy A ^e   Sepulveda, Cecilia R ^e   Hontelez, Jan A C ^a,f   Baltussen, Rob ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GHANA HEALTH SERVICE   (Ghana)

^c UNIVERSITY OF GHANA   (Ghana)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Cost effectiveness; Developing countries; Ghana policy; Non communicable diseases

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; TAMOXIFEN; ZOLEDRONIC ACID;

CANCER; COST-BENEFIT ANALYSIS; DEVELOPING WORLD; EPIDEMIOLOGY; HEALTH IMPACT; HEALTH POLICY; NUMERICAL MODEL; PUBLIC HEALTH; SURVIVAL; UNCERTAINTY ANALYSIS; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; ARTICLE; AWARENESS; BREAST CANCER; BREAST EXAMINATION; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SCREENING; CHILD; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL BREAST EXAMINATION; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DISABILITY ADJUSTED LIFE YEAR; DISEASE SEVERITY; ECONOMIC ASPECT; EPIDEMIOLOGICAL DATA; FEMALE; GHANA; HEALTH CARE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASS MEDIA AWARENESS RAISING; MASS MEDIUM; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PARTIAL MASTECTOMY; PRESCHOOL CHILD; QUALITY ADJUSTED LIFE YEAR; SCHOOL CHILD; WHO CHOICE METHOD; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AWARENESS; BREAST NEOPLASMS; COSTS AND COST ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; GHANA; HEALTH EDUCATION; HUMANS; MAMMOGRAPHY; MASS MEDIA; MIDDLE AGED; MODELS, ECONOMIC; NEOPLASM STAGING; PALLIATIVE CARE; SOCIOECONOMIC FACTORS;

GHANA;

EID: 84864385817     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2012.03021.x     Document Type: Article

References (52)

1. Adjuvant! Online. Decision making tools for health care professionals. (accessed on 1 May 2010).
2. Anderson BO, Shyyan R, Eniu A et al. (2006) Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. The Breast Journal 12(Suppl 1), S3-S15.
3. Anderson BO, Cazap E, El Saghir NS et al. (2011) Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus 2010. The Lancet Oncology 12, 387-398.
4. Bland KI, Menck HR, Scott-Conner CE et al. (1998) The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 83, 1262-1273.
5. Bobo JK, Lee NC & Thames SF (2000) Findings from 752, 081 clinical breast examinations reported to a national screening program from 1995 through 1998. Journal of the National Cancer Institute 92, 971-976.
6. Broekx S, Den Hond E, Torfs R et al. (2011) The costs of breast cancer prior to and following diagnosis. The European Journal of Health Economics 12, 311-317.
7. Brown M, Goldie S, Draisma G, Harford J & Lipscomb J (2006) Disease control priorities in developing countries. In: Health Service Interventions for Cancer Control in Developing Countries, 2nd edn (eds D Jamison, J Breman, A Measham, G Alleyne, M Claeson, D Evans, P Jha, A Mills & P Musgrove) World Bank, Washington, DC, pp. 569-589.
8. Clegg-Lamptey JN, Aduful HK, Yarney J et al. (2009a) Profile of breast diseases at a self-referral clinic in Ghana. West African Journal of Medicine 28, 114-117.
9. Clegg-Lamptey JN, Dakubo JC & Attobra YN (2009b) Psychosocial aspects of breast cancer treatment in Accra, Ghana. East African Medical Journal 86, 348-353.
10. Connor SR, Pyenson B, Fitch K, Spence C & Iwasaki K (2007) Comparing hospice and nonhospice patient survival among patients who die within a three-year window. Journal of Pain and Symptom Management 33, 238-246.
11. Devi BC, Tang TS & Corbex M (2007) Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4years: a pilot study of clinical downstaging in Sarawak, Malaysia. Annals of Oncology 18, 1172-1176.
12. Devi BC, Tang TS & Corbex M (2008) Setting up home-based palliative care in countries with limited resources: a model from Sarawak, Malaysia. Annals of Oncology 19, 2061-2066.
13. Duffy SW & Gabe R (2005) What should the detection rates of cancers be in breast screening programmes? British Journal of Cancer 92, 597-600.
14. Edejer T-TT, Baltusssen R, Adam T et al. (2003) WHO Guide to Cost-Effectiveness Analysis. World Health Organization, Geneva.
15. Elmore JG, Barton MB, Moceri VM et al. (1998) Ten-year risk of false positive screening mammograms and clinical breast examinations. New England Journal of Medicine 338, 1089-1096.
16. Engel J, Baumert J, Dirschedl P, Sauer H & Hölzel D (2000) Effectiveness of self-examination, palpation and mammography for the early detection of breast cancer: first results of the Munich Field Study, [in German]. Geburtsh Frauenheilk 60, 155-164.
17. Evans DB, Lim SS, Adam T & Edejer TT (2005) Evaluation of current strategies and future priorities for improving health in developing countries. BMJ 331, 1457-1461.
18. Fletcher SW & Elmore JG (2005) False-positive mammograms - can the USA learn from Europe? Lancet 365, 7-8.
19. Flobbe K, Van Linden Der ES, Kessels AG & Van Engelshoven JM (2001) Diagnostic value of radiological breast imaging in a non-screening population. International Journal of Cancer 92, 616-618.
20. Fracheboud J, De Gelder R & Van Ineveld BM (2009) National Evaluation of Breast Cancer Screening in the Netherlands 1990-2007. Twelfth evaluation report. National Evaluation Team for Breast cancer screening (NETB), Rotterdam.
21. Ghana Statistical Service (2010) Population Structure and demography. (accessed on 1 February 2011).
22. Ginsberg G, Lauer JA, Zelle S, Baeten S & Baltussen R (2012) Cost, effects and cost-effectiveness of strategies to combat breast, cervical and colorectal cancer in developing countries: a mathematical modelling study. BMJ 344, e614.
23. Greene FL, Compton CC, Fritz AG & Al E (2006) AJCC Cancer Staging Atlas Springer Inc., New York, NY.
24. Groot MT, Baltussen R, Uyl-De Groot CA, Anderson BO & Hortobagyi GN (2006) Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. The Breast Journal 12(Suppl 1), S81-S90.
25. Harford JB, Otero IV, Anderson BO et al. (2011) Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative. Breast 20(Suppl 2), S20-S29.
26. Hortobagyi GN (2002) Novel approaches to the management of bone metastases in patients with breast cancer. Seminars in Oncology 29, 134-144.
27. IARC (2008) World Cancer Report 2008. (accessed on 15 April 2011).
28. Khan SA, Stewart AK & Morrow M (2002) Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 132, 620-626; discussion 626-627.
29. Kumar SK (2007) Kerala, India: a regional community-based palliative care model. Journal of Pain and Symptom Management 33, 623-627.
30. Lauer JA, Rohrich K, Wirth H et al. (2003) PopMod: a longitudinal population model with two interacting disease states. Cost Effectiveness and Resource Allocation 1, 6.
31. Miller AB (2008) Practical Applications for Clinical Breast Examination (CBE) and Breast Self-Examination (BSE) in Screening and Early Detection of Breast Cancer. Breast Care (Basel) 3, 17-20.
32. Miller AB, To T, Baines CJ & Wall C (1997) The Canadian National Breast Screening Study: update on breast cancer mortality. Journal of the National Cancer Institute. Monographs 3, 7-41.
33. Mittra I, Mishra GA, Singh S et al. (2010) A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. International Journal of Cancer 126, 976-984.
34. Mushlin AI, Kouides RW & Shapiro DE (1998) Estimating the accuracy of screening mammography: a meta-analysis. American Journal of Preventive Medicine 14, 143-153.
35. National Health Insurance Authority (2010) Annual Report. Accra: National Health Insurance Scheme. (accessed on January 30 2012).
36. Oestreicher N, White E, Lehman CD et al. (2002) Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Research and Treatment 76, 73-81.
37. Ohene-Yeboah M (2008) Breast pain in Ghanaian women: clinical, ultrasonographic, mammographic and histological findings in 1612 consecutive patients. West African Journal of Medicine 27, 20-23.
38. Okonkwo QL, Draisma G, Der Kinderen A, Brown ML & De Koning HJ (2008) Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. Journal of the National Cancer Institute 100, 1290-1300.
39. Parkin DM, Sitas F, Chirenje M et al. (2008) Part I: cancer in Indigenous Africans - burden, distribution, and trends. The Lancet Oncology 9, 683-692.
40. Pisani P, Parkin DM, Ngelangel C et al. (2006) Outcome of screening by clinical examination of the breast in a trial in the Philippines. International Journal of Cancer 118, 149-154.
41. Radice D & Redaelli A (2003) Breast cancer management: quality-of-life and cost considerations. Pharmacoeconomics 21, 383-396.
42. Shulman LN, Willett W, Sievers A & Knaul FM (2010) Breast cancer in developing countries: opportunities for improved survival. Journal of Oncology 2010, 595167.
43. Thomas DB, Gao DL, Ray RM et al. (2002) Randomized trial of breast self-examination in Shanghai: final results. Journal of the National Cancer Institute 94, 1445-1457.
44. Walsh D & Rybicki L (2006) Symptom clustering in advanced cancer. Supportive Care in Cancer 14, 831-836.
45. WHO (2008) Global Burden of Disease 2004 update. (accessed on 20 June 2011).
46. WHO (2010) World Health Statistics. (accessed on 10 November 2010).
47. WHO (2011a) Choosing interventions that are cost effective. (accessed on 1 February 2011).
48. WHO (2011b) Department of Chronic Diseases and Health Promotion (CHP). (accessed on 1 February 2011).
49. WHO Commission on Macroeconomics and Health (2011) Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health. (accessed on 20 June 2011).
50. WHO Department of Essential Health Technologies (2005) Essential Health Care Technology Package (EHTP). (accessed on 15 May 2010).
51. Wiredu EK & Armah HB (2006) Cancer mortality patterns in Ghana: a 10-year review of autopsies and hospital mortality. BMC Public Health 6, 159.
52. Zotov V & Shyyan R (2003) Introduction of breast cancer screening in Chernihiv Oblast in the Ukraine: report of a PATH Breast Cancer Assistance Program experience. The Breast Journal 9(Suppl 2), S75-S80.